Budweiser Brewing Company (1876)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 22 Oct 2026
Key indicators
| Last close | HKD 5.855 |
|---|---|
| 52-week range | 5.555 – 8.480 |
| Return, 1 month / 3 months | −2.8% / −12.5% |
| Return, 1 year / 3 years | −23.5% / −52.8% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 26.4% |
| Worst drawdown (1 year) | -29.0% |
| Average daily value traded | 110.80M HKD |
| Dividend yield | 7.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Budweiser Brewing Company is the Asia-Pacific beer business of Anheuser-Busch InBev, based in Hong Kong and operating across the region. It brews, imports and distributes beer, selling international brands such as Budweiser, Stella Artois, Corona and Hoegaarden alongside local labels to consumers in markets including China, South Korea, India and Vietnam. Its customers are drinkers buying beer through retailers, restaurants, bars and other outlets, and it also offers some non-beer drinks.
Budweiser Brewing Company trades under the code 1876 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Budweiser Brewing Company (1876) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 5.855 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 607 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.5% and over the last three months it fell 12.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -13.4% | ||
| From 52-week high | -30.3% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.5% | ||
| 6-month return | -17.8% | ||
| 12-month return, skipping the last month | -21.3% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.0% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 110.80M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −2.8% |
| 3 months | −12.5% |
| 6 months | −17.8% |
| 1 year | −23.5% |
| 3 years | −52.8% |
| 5 years | −63.8% |
Signals
| 50-day / 200-day average | 6.009 / 6.764 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.158 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 May 2026 | HKD 0.4425 |
| 21 May 2025 | HKD 0.4396 |
| 22 May 2024 | HKD 0.4128 |
| 15 May 2023 | HKD 0.2961 |
| 16 May 2022 | HKD 0.2368 |
| 17 May 2021 | HKD 0.2196 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.